AKIN GUMP STRAUSS HAUER & FELD

Lobbying for MAYNE PHARMA (USA), INC. · Pharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $70,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to coverage of contraceptive products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem